MedTrace Logo

IU Health Krannert Personalized Medicine Study

NCT02955121 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2020-07-28

No results posted yet for this study

Summary

Randomized controlled study to examine physician use of pharmacogenetic information in patients receiving antiplatelet medication after percutaneous coronary intervention (PCI).

Conditions

Interventions

OTHER

Prescriber Access to Genetic Information

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Rolf Kreutz, MD · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2019-08-09
Completion
2020-01-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02955121 on ClinicalTrials.gov